• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对太平洋西北地区一个县监狱的阿片类药物使用障碍服务的自我评估。

A self-assessment of opioid use disorder services at a Pacific Northwest County jail.

作者信息

Schumacher Joseph E, Bell Scott A, Ahsan Abdullah, Cochran Phillip R, Gutierrez Allan G, Morris Emma R, Cain Bradley J

机构信息

NaphCare Charitable Foundation, Inc, 2101 Old Columbiana Road, Suite 100, 35216, Birmingham, AL, USA.

NaphCare, Inc, 2090 Columbiana Rd. Ste 4000, 35216, Birmingham, AL, USA.

出版信息

Subst Abuse Treat Prev Policy. 2025 Aug 13;20(1):31. doi: 10.1186/s13011-025-00667-5.

DOI:10.1186/s13011-025-00667-5
PMID:40804633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12351882/
Abstract

This study describes the delivery of opioid use disorder (OUD) services in a Pacific Northwest County jail focusing on screening, assessment, withdrawal management, and medications for opioid use disorder (MOUD). Guided by the 2023 Medicaid performance measures, self-assessment data were collected through stakeholder interviews, policy and electronic healthcare records (EHR) analyses, and a systematic survey focusing on conformity to practice, policy, and documentation. This jail provided OUD screening, assessment, withdrawal management, and MOUD supported by institutional policy and an EHR software system. Survey results confirmed strong conformity to the 2023 Medicaid performance measures, with 91.9% of required recommendations met for policy and practice domains and 87.9% for documentation. Optional (not required) recommendations achieved 80.0% conformity for policy, 93.3% for practice, and 60.0% for documentation. The findings from this self-assessment underscore the robust implementation of OUD services in one jail and can inform internal and external performance improvement goals and activities. (150 words).

摘要

本研究描述了太平洋西北地区一个县监狱中阿片类物质使用障碍(OUD)服务的提供情况,重点关注筛查、评估、戒断管理以及阿片类物质使用障碍药物治疗(MOUD)。以2023年医疗补助绩效指标为指导,通过利益相关者访谈、政策及电子健康记录(EHR)分析,以及一项侧重于实践、政策和文档合规性的系统调查收集自我评估数据。该监狱在机构政策和EHR软件系统的支持下提供OUD筛查、评估、戒断管理及MOUD。调查结果证实,与2023年医疗补助绩效指标高度相符,政策和实践领域达到91.9%的要求建议,文档方面达到87.9%。可选(非必需)建议在政策方面达到80.0%的合规率,实践方面为93.3%,文档方面为60.0%。此次自我评估结果突显了一所监狱中OUD服务的有力实施,并可为内部和外部的绩效改进目标及活动提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f007/12351882/93ff058e3190/13011_2025_667_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f007/12351882/93ff058e3190/13011_2025_667_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f007/12351882/93ff058e3190/13011_2025_667_Fig1_HTML.jpg

相似文献

1
A self-assessment of opioid use disorder services at a Pacific Northwest County jail.对太平洋西北地区一个县监狱的阿片类药物使用障碍服务的自我评估。
Subst Abuse Treat Prev Policy. 2025 Aug 13;20(1):31. doi: 10.1186/s13011-025-00667-5.
2
Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails.美国监狱中阿片类药物使用障碍通用药物可及性的障碍
JAMA Netw Open. 2025 Apr 1;8(4):e255340. doi: 10.1001/jamanetworkopen.2025.5340.
3
Systems analysis and improvement to optimize opioid use disorder care quality and continuity for patients exiting jail (SAIA-MOUD).系统分析与改进,以优化出狱患者阿片类药物使用障碍护理的质量和连续性(SAIA-MOUD)。
Implement Sci. 2024 Dec 18;19(1):80. doi: 10.1186/s13012-024-01409-0.
4
Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study.阿片类物质使用障碍的监狱内药物治疗与社区持续治疗之间的照护过渡:一项回顾性队列研究。
Drug Alcohol Depend. 2024 Aug 1;261:111377. doi: 10.1016/j.drugalcdep.2024.111377. Epub 2024 Jun 24.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Examining use of telehealth in jails: linking women to community OUD services.监狱中远程医疗的应用:将女性与社区 OUD 服务联系起来。
BMC Womens Health. 2024 Oct 4;24(1):549. doi: 10.1186/s12905-024-03394-4.
7
"Yeah, this is not going to work for me"-The impact of federal policy restrictions on methadone continuation upon release from jail or prison.“是的,这对我行不通”——联邦政策限制对从监狱获释后美沙酮维持治疗的影响。
J Subst Use Addict Treat. 2025 Jan;168:209538. doi: 10.1016/j.josat.2024.209538. Epub 2024 Oct 10.
8
The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder.阿片类药物使用障碍治疗研究:18 个月阿片类药物使用障碍治疗患者的研究方法和初步结果。
Public Health Rep. 2024 Jul-Aug;139(4):484-493. doi: 10.1177/00333549231222479. Epub 2024 Jan 25.
9
Initiation and Receipt of Medication for Opioid Use Disorder Among Adolescents and Young Adults in 4 State Medicaid Programs in 2018: Improving Medicaid Quality Metrics.2018 年,在四个州的医疗补助计划中,青少年和年轻人开始接受阿片类药物使用障碍治疗药物的比例:提高医疗补助质量指标。
Subst Use Addctn J. 2024 Jul;45(3):434-445. doi: 10.1177/29767342241227791. Epub 2024 Jan 31.
10
Clinical Decision Support System for Primary Care of Opioid Use Disorder: A Randomized Clinical Trial.阿片类物质使用障碍基层医疗临床决策支持系统:一项随机临床试验
JAMA Intern Med. 2025 Jul 14. doi: 10.1001/jamainternmed.2025.2535.

本文引用的文献

1
An investigation of drug use among first-time arrestees from 25 county jails across the United States in 2023.2023年对美国25个县监狱首次被捕者的药物使用情况进行的一项调查。
Addict Sci Clin Pract. 2025 Mar 7;20(1):23. doi: 10.1186/s13722-025-00550-5.
2
Medication for opioid use disorder service delivery in carceral facilities: update and summary report.监狱设施中阿片类药物使用障碍服务提供的药物治疗:最新情况及总结报告
Health Justice. 2025 Feb 1;13(1):8. doi: 10.1186/s40352-025-00317-9.
3
Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails.
与美国监狱中阿片类药物使用障碍药物供应相关的因素。
JAMA Netw Open. 2024 Sep 3;7(9):e2434704. doi: 10.1001/jamanetworkopen.2024.34704.
4
Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis.干预措施以减少监禁人群中与药物使用相关的危害:系统评价和荟萃分析。
Lancet Public Health. 2024 Sep;9(9):e684-e699. doi: 10.1016/S2468-2667(24)00160-9.
5
Re-examining mandatory drug testing in Australian prisons.重新审视澳大利亚监狱中的强制性药物检测。
Drug Alcohol Rev. 2024 Nov;43(7):1654-1656. doi: 10.1111/dar.13894. Epub 2024 Jul 7.
6
Jail Characteristics and Availability of Opioid Treatment Services: Results from a Nationally Representative Survey.监狱特征与阿片类药物治疗服务的可及性:一项全国代表性调查的结果。
J Behav Health Serv Res. 2024 Jul;51(3):313-324. doi: 10.1007/s11414-024-09881-8. Epub 2024 Mar 22.
7
Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.扩大监狱中阿片类药物使用障碍(MOUD)药物的获取途径:一项综合项目评估。
J Subst Use Addict Treat. 2024 Jun;161:209248. doi: 10.1016/j.josat.2023.209248. Epub 2023 Dec 9.
8
The End of the X-waiver: Excitement, Apprehension, and Opportunity.X 豁免的终结:兴奋、担忧与机遇。
J Am Board Fam Med. 2023 Oct 11;36(5):867-872. doi: 10.3122/jabfm.2023.230048R1. Epub 2023 Sep 13.
9
Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.4 个美国州维持公共卫生干预措施估计可减少阿片类药物过量死亡人数。
JAMA Netw Open. 2023 Jun 1;6(6):e2314925. doi: 10.1001/jamanetworkopen.2023.14925.
10
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts.马萨诸塞州监禁期间和释放后使用和不使用阿片类药物使用障碍药物相关的估计费用和结果。
JAMA Netw Open. 2023 Apr 3;6(4):e237036. doi: 10.1001/jamanetworkopen.2023.7036.